Clinical Trial Update: Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a regimen of Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium-90 ibritumomab tiuxetan in previously untre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Oncovin (vincristine)
• Rituxan (rituximab)
• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 2 | Status: COMPLETED